FEDERATED HERMES, INC. - CHEMOCENTRYX INC ownership

CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 195 filers reported holding CHEMOCENTRYX INC in Q4 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.

Quarter-by-quarter ownership
FEDERATED HERMES, INC. ownership history of CHEMOCENTRYX INC
ValueSharesWeighting
Q1 2022$1,232,000
-86.7%
49,161
-91.0%
0.00%
-83.3%
Q3 2021$9,294,000
+340.5%
543,502
+1495.1%
0.02%
+350.0%
Q4 2020$2,110,000
-16.8%
34,073
-26.3%
0.00%
-33.3%
Q3 2020$2,535,000
-35.9%
46,261
-32.6%
0.01%
-40.0%
Q2 2020$3,952,000
+159.1%
68,674
+81.0%
0.01%
+150.0%
Q1 2020$1,525,000
+131.8%
37,948
+128.1%
0.00%
+300.0%
Q4 2019$658,000
+298.8%
16,636
-31.9%
0.00%
Q3 2019$165,000
-88.2%
24,418
-83.8%
0.00%
-100.0%
Q2 2019$1,403,000
+17437.5%
150,826
+27830.7%
0.00%
Q1 2019$8,000
-98.9%
540
-99.2%
0.00%
-100.0%
Q4 2018$717,000
-13.7%
65,7610.0%0.00%0.0%
Q3 2018$831,000
-5.2%
65,761
-1.2%
0.00%
-33.3%
Q2 2018$877,000
+19.8%
66,569
+23.7%
0.00%
+50.0%
Q1 2018$732,000
+90.6%
53,810
-16.7%
0.00%
+100.0%
Q4 2017$384,000
-19.8%
64,6100.0%0.00%0.0%
Q3 2017$479,000
-54.0%
64,610
-41.9%
0.00%
-66.7%
Q2 2017$1,041,000
+36.4%
111,230
+6.1%
0.00%
+50.0%
Q1 2017$763,000
+11.9%
104,831
+13.8%
0.00%0.0%
Q4 2016$682,000
+8425.0%
92,096
+6468.9%
0.00%
Q3 2016$8,000
+60.0%
1,402
+15.0%
0.00%
Q2 2016$5,000
-66.7%
1,219
-31.9%
0.00%
Q2 2015$15,000
+150.0%
1,789
+141.8%
0.00%
Q1 2015$6,0007400.00%
Other shareholders
CHEMOCENTRYX INC shareholders Q4 2021
NameSharesValueWeighting ↓
Tri Locum Partners LP 276,400$4,726,0001.88%
TANG CAPITAL MANAGEMENT LLC 500,000$8,550,0001.78%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 94,300$7,131,0001.72%
Integral Health Asset Management, LLC 300,000$5,130,0001.48%
SILVERARC CAPITAL MANAGEMENT, LLC 139,200$2,380,0001.35%
MANGROVE PARTNERS IM, LLC 686,300$11,736,0001.05%
Ikarian Capital, LLC 600,000$10,261,0000.72%
Ikarian Capital, LLC 600,000$10,260,0000.72%
Sofinnova Investments, Inc. 517,708$8,853,0000.52%
Birchview Capital, LP 25,000$428,0000.29%
View complete list of CHEMOCENTRYX INC shareholders